 | | | | Syria said on Monday that 29 people had died of cholera in what the United Nations has called the worst outbreak of the disease in the war-torn country for years. | | | | | | Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. | | | | | | Canada will drop all COVID-19 restrictions for travelers from Oct. 1, including vaccination and masking requirements for flights and trains, the government said on Monday. | | | | | | Britain's GSK has appointed its first female chief financial officer, Julie Brown, to succeed Iain Mackay, as the drugmaker focuses on its core pharmaceuticals business. | | | | | | French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets new variants of the disease, sending its shares up. | | | | | | A thousand days since the World Health Organization (WHO) was told of a "viral pneumonia" in central China, many countries have returned to pre-COVID-19 life. Not so China itself - in cities big or small, routine PCR testing is the new normal. | | | | | | China reported 999 new COVID-19 infections on Sept. 25, of which 295 were symptomatic and 704 were asymptomatic, the National Health Commission said on Monday. | | | | | | Prominent Chinese commentator Hu Xijin said on Sunday that as China ponders its COVID-19 policies, epidemic experts need to speak out and China ought to conduct comprehensive research and make any studies transparent to the public. | | | | | | Albert Bourla had contacted the virus in August and took a course of the company's oral COVID-19 antiviral treatment, Paxlovid. He said he has not yet taken the new bivalent booster. | | | | | |
